Edition:
United States

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

124.48USD
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
$124.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
196,680
52-wk High
$141.13
52-wk Low
$97.80

LH.N

Chart for LH.N

About

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The Company's LCD... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $12,990.36
Shares Outstanding(Mil.): 103.00
Dividend: --
Yield (%): --

Financials

  LH.N Industry Sector
P/E (TTM): 19.89 37.86 29.87
EPS (TTM): 6.34 -- --
ROI: 5.28 8.96 14.95
ROE: 12.69 12.46 16.29

BRIEF-Laboratory Corporation of America reports Q3 EPS $1.71

Oct 26 Laboratory Corporation Of America Holdings

Oct 26 2016

BRIEF-Emulate, Laboratory Corp of America to integrate organs-on-chips tech in drug evaluation

Oct 20 Laboratory Corporation Of America Holdings:

Oct 20 2016

BRIEF-Oxford Immunotec announces favorable recommendation by the magistrate judge

* Oxford Immunotec announces favorable recommendation by the magistrate judge in patent infringement litigation

Sep 01 2016

BRIEF-Labcorp's acquisition of Sequenom clears antitrust review

Aug 23 Laboratory Corporation Of America Holdings :

Aug 23 2016

BRIEF-Laboratory Corporation of America announces availability of CDC Zika Mac-Elisa test

Aug 2 Laboratory Corporation Of America Holdings:

Aug 02 2016

BRIEF-Labcorp to acquire Sequenom

July 27 Laboratory Corporation Of America Holdings

Jul 27 2016

BRIEF-LabCorp reports Q2 adjusted earnings per share of $2.31

July 27 Laboratory Corporation Of America Holdings

Jul 27 2016

Diagnostics company LabCorp to buy smaller rival Sequenom

Laboratory Corporation of America Holdings said it would buy Sequenom Inc , a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt.

Jul 27 2016

Diagnostics company LabCorp to buy smaller rival Sequenom

July 27 Laboratory Corporation of America Holdings said it would buy Sequenom Inc, a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt.

Jul 27 2016

Earnings vs. Estimates